# Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation

> **NCT00562471** · PHASE1,PHASE2 · COMPLETED · sponsor: **Angiotech Pharmaceuticals** · enrollment: 76 (actual)

## Conditions studied

- Myoma

## Interventions

- **OTHER:** Adhibit Adhesion Prevention Gel
- **OTHER:** Standard of Care Comparator

## Key facts

- **NCT ID:** NCT00562471
- **Lead sponsor:** Angiotech Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2007-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00562471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00562471, "Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00562471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*